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Abstract
Introduction: Bilateral ovarian metastases from a clear cell renal carcinoma are uncommon findings
and need to be differentiated from primary cancers. Diagnostic imaging and histopathological features
are often inconclusive, unless they are combined.
Case presentation: A 56-year-old woman with a history of right radical nephrectomy for a renal
clear cell carcinoma diagnosed 10 years earlier was referred for abdominal distension and pelvic pain.
Color-Doppler US and Computer Tomography scan revealed the presence of bilateral ovarian
masses with regular margins, a low resistance index and poor contrast enhancement.
Immunohistochemistry showed positive epithelial membrane antigen, cytokeratin, vimentin and
CD10, suggesting clear cells from the previously diagnosed kidney cancer.
Conclusion: Although bilateral metachronous ovarian metastases from clear cell renal carcinoma
are a very uncommon finding, they can be considered in the differential diagnosis and investigated
with imaging and immunohistochemistry. The 6 cases reported in the literature indicate a good
prognosis for this condition.
Introduction
Ovarian metastases from a renal clear cell carcinoma are
uncommon events, which has been described in 19 case
reports [1–6]. Some of these secondary lesions are
metachronous to the primary tumor, and the vast majority
is monolateral [6].
We report a case of bilateral metachronous ovarian
metastases from a primary renal clear cell carcinoma
(stage I) removed 10 years earlier. Such an unusual finding
has been reported in 5 more cases [1–5].
We will discuss clinical presentation, differential diagnosis,
imagingfeatures,treatmentandprognosisofthiscondition.
Case presentation
A 56-year-old Caucasian Italian woman was admitted to
our hospital for abdominal distension and pelvic pain.
Ten years earlier she had undergone right radical
nephrectomy for a stage-I clear cell carcinoma. Following
the operation, the patient had not received any adjuvant
chemotherapy, but no metastatic cancer was detected at
any step of the follow-up.
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pelvic masses, while blood tests showed a significant
increase in Ca-125 (1006 U/ml).
A transvaginal ultrasound examination showed ascites in
all pelvic quadrants. Both ovaries were small, presenting
cystic areas not larger than 3 centimeters (Figure 1). Color-
Doppler US showed some vessels with a low resistance
index (RI = 0.8).
An abdomino-pelvic multislice CT scan (Sensation 16,
Siemens) was performed with acquisitions in the portal
phase (70 seconds delay) after I.V. administration of non-
ionic iodinate contrast agent (Xenetix 350, Guerbet).
The CT study clarified the extent of the ascites (involving
the whole abdomen and pelvis) and revealed the presence
of ovarian bilateral masses with regular margins and poor
contrast enhancement (Figure 2).
There were no tumor recurrences around the
nephrectomy site, nor any intra-abdominal or pelvic
lymphadenopathies.
A laparoscopic hysterectomy with double oophorectomy
was performed. Macroscopically, it looked like both
ovaries had been completely replaced by a solid/cystic
yellowish mass with multiple hemorrhagic areas.
On microscopic examination, both masses were popu-
lated by polygonal cells with clear cytoplasm and relatively
uniform nuclei, some of them exhibiting prominent
nucleoli. Tumor cells were arranged in solid sheets and
tubular areas, often dilated and containing eosinophilic
fluid or blood. In both tubular and solid areas prominent
thin-walled blood vessels were recognized (Figure 3). The
ascitic fluid was free of malignant cells. Immunohisto-
chemistry of the masses revealed strong and diffuse
expression of EMA, cytokeratin, vimentin and CD 10 in
tumor clear cells (Figure 4). Immunostainings for cytoker-
atin 7, cytokeratin 20,inhibin, CA 125, PLAP, estrogen and
Figure 1. Endocavitary US shows a cystic mass in the right
ovary, which appears enlarged. Intraperitoneal free fluid.
Figure 2. Contrast enhanced CT, portal phase. Presence of
bilateral mostly solid parenchymatous ovarian masses with
poor contrast enhancement and regular and smooth margins.
The scan shows no uterine abnormalities.
Figure 3. The ovarian parenchyma is almost completely
replaced by a clear cell carcinoma consisting in alveolar nests,
tubular structures and solid sheaths; there are numerous
blood vessels. Tubular structures are composed of polygonal
cells with abundant clear cytoplasm and relatively uniform
nuclei.
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fin 1 and CD 34 were uniformly negative for tumor cells.
Based on morphologic findings and cancer cell phenotype,
the diagnosis was bilateral ovarian metastases from the
known renal clear cell carcinoma.
Chemotherapy as an adjuvant treatment was offered, but
the patient declined in view of unpleasant collateral
effects.
She is currently alive with no evidence of disease 19
months after the diagnosis of relapse.
Discussion
In the literature there are 19 cases of renal clear cell
carcinoma metastasized to the ovaries, 5 of which are
bilateral and metachronous [1–5].
Table 1 summarizes demographic features of the other
bilateral metastases. Presenting symptoms were aspecific
in all cases. All patients were still alive after an average
follow-up of 27 months (ranging from 6 to 48 months).
Two patients were found to have a disease relapse [2,4].
Spencer [2] reported metastases to the parotid gland,
thyroid and brain at 18 months, which were treated with
surgery and radiation therapy; the patient was alive with
disease 48 months later. The patient presented by Valappil
[4] developed tumor recurrences to pelvic and para-aortic
nodes 8 months after ovarian metastases and was treated
with interferon but metastases persisted.
Drug treatment after the finding of adnexal metastases was
administered only in two of the literature reports [3,4]; an
inhibitor of cell proliferation (interferon alpha) was used
in both cases. Survival does not significantly change in
treated versus untreated patients (35 versus 26 months).
Based on these outcomes the prognosis of the metastatic
cancer in question could be considered favorable.
One of the uncommon features in our case is the finding
of ascites without peritoneal and parenchymal spread, as
well as lymph node sparing at the operation site despite
the presence of metastases.
The differential diagnosis of ovarian malignancies in these
cases can be awkward, particularly when we need to
Figure 4. Tumor cells strongly expressing CD10.
Table 1. Summary table of the literature cases of metachronous bilateral ovarian metastases from clear cell renal carcinoma
Author Age Time of
recurrence
(yrs)
Presentation Follow up/
Survival
(months)
Treatment (in chronological order) Outcome
Vara 66 14 Right abdominal pain 24 - R-Nephrectomy
- Total Hysterectomy + double adnexectomy
NED
Spencer 42 * Bilateral flank pain 48 - Total Hysterectomy + double adnexectomy
- L-Nephrectomy
- Radiation therapy to metastases (other
organs)
AD
Adachi 46 3 Vaginal bleeding 36 - L-Nephrectomy
- Total Hysterectomy + double adnexectomy
NED
Valappil 61 7 Dysuria 24 - L-nephrectomy
- Splenectomy, omentectomy for recurrence
(after 5 years)
- Double adnexectomy
- Interferon
AD
Vorder-Bruegge 64 11 Bowel obstruction/ Ascitis 6 - R-Nephrectomy
- Double adnexetomy
NED
Our case 56 10 Pelvic pain 15 - R-Nephrectomy
- Total Hysterectomy + double adnexectomy
NED
NED (no evidence of disease); AD (alive with disease).
* Clear cell renal carcinoma detected 6 months after bilateral salpingo-oophorectomy.
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detect any unquestionable morphological sign of ovarian
metastases even using different imaging techniques [4,8].
Several attempts have been made to try to find some
typical features associated with the radiological appear-
ance of ovarian metastases.
Some authors indicate that ovarian metastases are mostly
solid, small and bilateral [7].
In a separate study performed on a cohort of patients with
stomach and colonic cancers, we observed that bilateral
ovarian masses with clear-cut margins, associated with
peritoneal carcinomatosis and with no ascites, are of
metastaticnatureinmostcases[8].Someofthemorphologic
features in this case are in agreement with those findings
(bilateral presentation, clear-cut margins), unlike the pre-
sence of ascites and theabsenceof peritonealcarcinomatosis.
However, the radiological characteristics that could make a
safe difference between ovarian metastases and clear cell
carcinoma of the kidney have not yet been established: not
enough experimental studies have been performed so far
and literature reports are too few to allow unquestionable
conclusions to be drawn.
For the time being, with the help of pathologic findings
(structural features and immunohistochemical profile, i.e.
positivity for CD10, cytokeratin and CA 125) we can make
the safer differential diagnosis.
We would like to reiterate theimportance of apast medical
history positive for renal tumor, which was the first
fundamental element of suspicion in our case.
In conclusion, the unreliable nature of metastatic renal
cancer makes it worth considering this possibility in the
differential diagnosis of any suspicious abdominal mass.
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